Enovix (NASDAQ:ENVX) Trading Up 3.9% – Here’s Why

Enovix Co. (NASDAQ:ENVXGet Free Report)’s share price rose 3.9% during mid-day trading on Thursday . The stock traded as high as $11.04 and last traded at $10.93. Approximately 988,942 shares traded hands during trading, a decline of 82% from the average daily volume of 5,434,890 shares. The stock had previously closed at $10.52.

Wall Street Analyst Weigh In

ENVX has been the subject of several research analyst reports. Craig Hallum raised their target price on Enovix from $15.00 to $20.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. cut their target price on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday. Piper Sandler restated an “overweight” rating and issued a $19.00 target price (down previously from $23.00) on shares of Enovix in a research note on Monday, August 5th. TD Cowen raised their target price on Enovix from $11.00 to $14.00 and gave the stock a “hold” rating in a research note on Thursday, August 1st. Finally, Benchmark started coverage on Enovix in a research note on Monday, July 22nd. They issued a “buy” rating and a $25.00 target price for the company. One equities research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $21.67.

Read Our Latest Analysis on ENVX

Enovix Trading Down 4.3 %

The stock has a market cap of $1.84 billion, a P/E ratio of -6.51 and a beta of 1.98. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.84 and a current ratio of 3.98. The stock has a 50-day moving average price of $10.05 and a 200-day moving average price of $10.97.

Enovix (NASDAQ:ENVXGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $3.77 million during the quarter, compared to the consensus estimate of $3.85 million. Enovix had a negative return on equity of 91.21% and a negative net margin of 1,434.34%. On average, equities research analysts expect that Enovix Co. will post -1.21 EPS for the current year.

Insider Activity at Enovix

In related news, insider Arthi Chakravarthy sold 35,000 shares of the firm’s stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.00, for a total transaction of $455,000.00. Following the transaction, the insider now directly owns 343,305 shares of the company’s stock, valued at approximately $4,462,965. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 15.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Enovix

A number of large investors have recently modified their holdings of ENVX. Wellington Management Group LLP raised its holdings in shares of Enovix by 8.2% during the 4th quarter. Wellington Management Group LLP now owns 628,712 shares of the company’s stock valued at $7,871,000 after buying an additional 47,853 shares in the last quarter. Vanguard Group Inc. increased its stake in Enovix by 4.1% in the 4th quarter. Vanguard Group Inc. now owns 12,928,993 shares of the company’s stock worth $161,871,000 after purchasing an additional 513,508 shares during the period. Wealthcare Advisory Partners LLC increased its stake in Enovix by 36.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 14,694 shares of the company’s stock worth $118,000 after purchasing an additional 3,936 shares during the period. Udine Wealth Management Inc. increased its stake in Enovix by 1.9% in the 1st quarter. Udine Wealth Management Inc. now owns 137,314 shares of the company’s stock worth $1,100,000 after purchasing an additional 2,601 shares during the period. Finally, tru Independence LLC increased its stake in Enovix by 0.6% in the 1st quarter. tru Independence LLC now owns 303,435 shares of the company’s stock worth $2,431,000 after purchasing an additional 1,712 shares during the period. 50.92% of the stock is owned by hedge funds and other institutional investors.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.